Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
Premiere Oncology of Arizona
mi
from
Scottsdale, AZ
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
Premiere Oncology of Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
Indiana University Cancer Center
mi
from
Indianapolis, IN
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
LSU Health Sciences Center
mi
from
Shreveport, LA
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
LSU Health Sciences Center
mi
from
Shreveport, LA
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
The Mayo Clinic
mi
from
Rochester, MN
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
Sarah Cannon Research Institute
mi
from
Nashville, TN
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
UT Health and Science Center
mi
from
San Antonio, TX
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
UT Health and Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
Northwest Medical Specialties
mi
from
Tacoma, WA
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
Northwest Medical Specialties
mi
from
Tacoma, WA
Click here to add this to my saved trials
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  5/5/2015
University of Wisconsin
mi
from
Madison, WI
Dose-Escalation Study of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed to Treat Advanced Solid Tumors
A Phase 1/2, Multicenter, Dose-Escalation Study to Determine the Safety, Efficacy and Pharmacokinetics of TH-302 in Combination With A) Gemcitabine or B) Docetaxel or C) Pemetrexed in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 5/5/2015
University of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
A Phase I/II Study of Erlotinib and Romidepsin in Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  5/29/2015
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Romidepsin and Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
A Phase I/II Study of Erlotinib and Romidepsin in Advanced Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 5/29/2015
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase IIa Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
A Phase IIa Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Status: Enrolling
Updated:  7/2/2015
Stanford University Cancer Institute
mi
from
Stanford, CA
Phase IIa Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
A Phase IIa Intrapatient Dose Escalation Study of Desipramine in Small Cell Lung Cancer and Other High-Grade Neuroendocrine Tumors
Status: Enrolling
Updated: 7/2/2015
Stanford University Cancer Institute
mi
from
Stanford, CA
Click here to add this to my saved trials
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated:  7/6/2015
Clinical Research Facility
mi
from
Kentucky, KY
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated: 7/6/2015
Clinical Research Facility
mi
from
Kentucky, KY
Click here to add this to my saved trials
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated:  7/6/2015
Clinical Research Facility
mi
from
Maryland, MD
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated: 7/6/2015
Clinical Research Facility
mi
from
Maryland, MD
Click here to add this to my saved trials
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated:  7/6/2015
Clinical Research Facility
mi
from
Langhorne, PA
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated: 7/6/2015
Clinical Research Facility
mi
from
Langhorne, PA
Click here to add this to my saved trials
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated:  7/6/2015
mi
from
Beijing,
T790M Mutation Positive 2nd Line STandard of cAre Registry
T-STAR - T790M Mutation Positive 2nd Line STandard of cAre Registry
Status: Enrolling
Updated: 7/6/2015
mi
from
Beijing,
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
John Stoddard Cancer Center at Iowa Methodist Medical Center
mi
from
Des Moines, IA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Mercy Cancer Center at Mercy Medical Center - Des Moines
mi
from
Des Moines, IA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Iowa Lutheran Hospital
mi
from
Des Moines, IA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Midlands Cancer Center at Midlands Community Hospital
mi
from
Papillion, NE
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Midlands Cancer Center at Midlands Community Hospital
mi
from
Papillion, NE
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
MBCCOP - University of New Mexico HSC
mi
from
Albuquerque, NM
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
MBCCOP - University of New Mexico HSC
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Penn State Cancer Institute at Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Drexel University Hospital
mi
from
Philadelphia, PA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Drexel University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Hillman Cancer Center at University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
CCOP - MainLine Health
mi
from
Wynnewood, PA
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
CCOP - MainLine Health
mi
from
Wynnewood, PA
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
CCOP - St. Vincent Hospital Cancer Center, Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated:  7/6/2015
Westmead Hospital
mi
from
Westmead,
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
VIDEO ASSISTED WEDGE RESECTION (VAR) AND RADIOTHERAPY FOR HIGH RISK T1 NON-SMALL CELL LUNG CANCER: A PHASE II STUDY
Status: Enrolling
Updated: 7/6/2015
Westmead Hospital
mi
from
Westmead,
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Mobile Infirmary Medical Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
mi
from
Orange, CA
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center
mi
from
Orange, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Huntington Cancer Center at Huntington Hospital
mi
from
Pasadena, CA
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Huntington Cancer Center at Huntington Hospital
mi
from
Pasadena, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
UCSF Comprehensive Cancer Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Veterans Affairs Medical Center - Gainesville
mi
from
Gainesville, FL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Veterans Affairs Medical Center - Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Shands Cancer Center / University of Florida
mi
from
Gainesville, FL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Shands Cancer Center / University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Holmes Regional Medical Center
mi
from
Melbourne, FL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Holmes Regional Medical Center
mi
from
Melbourne, FL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Jackson Memorial Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Medical Center of Central Georgia
mi
from
Macon, GA
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Medical Center of Central Georgia
mi
from
Macon, GA
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Alexian Brothers Medical Center
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Loyola University Medical Center
mi
from
Maywood, IL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Edward Hospital Cancer Center
mi
from
Naperville, IL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Edward Hospital Cancer Center
mi
from
Naperville, IL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
St. Johns Hospital
mi
from
Springfield, IL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
St. Johns Hospital
mi
from
Springfield, IL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Southern Illinois University School of Medicine
mi
from
Springfield, IL
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Central Baptist Hospital
mi
from
Lexington, KY
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Central Baptist Hospital
mi
from
Lexington, KY
Click here to add this to my saved trials
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated:  7/6/2015
Jewish Hospital
mi
from
Louisville, KY
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient With N0 and N1 (Less Than Hilar) Non-Small Cell Carcinoma
Status: Enrolling
Updated: 7/6/2015
Jewish Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials